Capcom continues a very long winning streak after the company recently revealed that it had seven years of record profits, with updated sales figures provided for its major titles like Resident Evil 4 and Dragon’s Dogma 2. The Japanese developer and publisher has also announced an eleventh consecutive year of operating income growth.
Capcom’s resurgence dates back to 2017 with the launch of Resident Evil 7: Biohazard which successfully revived the franchise by bringing it back down to its survival horror roots. Since then – and with the exception of some outliers like Marvel vs. Capcom Infinite or Exoprimal – most Capcom games have been critically acclaimed hits and financial successes. This includes the Resident Evil 2, 3 and 4 remakes as well as Monster Hunter World and Rise, Devil May Cry 5 and Street Fighter 6.
In its financial results posted yesterday, Capcom revealed another year of record growth. Net sales were 152,410 million yen ($977M), which is up 21.0% year-over-year while operating income was 57,081 million yen ($366M) which is up 12.3% year-over-year. Additionally, ordinary income was 59,422 million yen ($381M), which is up 15.7 % year-over-year.
Capcom’s biggest hit last year was the Resident Evil 4 remake, which sold 3.3 million units during the recent financial period, bringing the lifetime sales of the game up to 7 million. Street Fighter 6 sold 3.3 million units since its launch in June last year, while Dragon’s Dogma 2 sold 2.6 million copies since release in March 2024. The Monster Hunter series has now crossed 100 million cumulative sales too.
Capcom has a few anticipated games on its schedule for the next fiscal year such as Monster Hunter Wilds, the sequel to Monster Hunter World and sixth mainline entry in the franchise. Rumours suggest that the publisher is also planning to release Resident Evil 9 before the end of March 2025, when the next fiscal year ends.
Source: Video Games Chronicle
